5 Stocks to Buy Before Stagflation Begins

2. Pfizer Inc. (NYSE:PFE)

Number of Hedge Fund Holders: 83  

Pfizer Inc. (NYSE:PFE) makes and sells biopharma products. The company has an impressive dividend history stretching back over three decades with twelve consecutive years of growing payouts, making the stock one of the most trustworthy names in the biopharma industry. 

The hedge fund sentiment around Pfizer Inc. (NYSE:PFE) stock is overwhelmingly positive. At the end of the fourth quarter of 2021, 83 hedge funds in the database of Insider Monkey held stakes worth $5 billion in Pfizer Inc. (NYSE:PFE), up from 74 in the preceding quarter worth $2.6 billion.

In its Q1 2021 investor letter, ClearBridge Investments, an asset management firm, highlighted a few stocks and Pfizer Inc. (NYSE:PFE) was one of them. Here is what the fund said:

“Our underweights in health care and staples contributed to relative performance during the period. As we continue to focus the portfolio on high-conviction ideas, we sold Pfizer Inc. (NYSE:PFE) in late 2020, in the health care sector.”